<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Eli Lilly Employees: Is Now the Time to Sell Your Home, or Should You Wait?

image-table

Healthcare Provider Update: Eli Lilly's primary healthcare provider initiatives are often tied to their pharmaceutical products and drug distribution networks, which include partnerships with a variety of healthcare systems and organizations to ensure that patients have access to their medications and therapies. Looking ahead to 2026, the healthcare landscape is expected to witness significant cost increases, particularly in health insurance premiums for Affordable Care Act (ACA) marketplace plans. With some states projecting hikes exceeding 60%, many individuals could see their out-of-pocket costs soar by over 75% if enhanced federal premium subsidies are not extended. This surge is driven by a combination of rising medical costs, including both hospital and prescription drug expenses, and the profitability pressures on insurers, prompting them to request substantial rate increases. As a result, consumers, especially those relying on ACA coverage, might face unprecedented financial strain in their quest for adequate healthcare. Click here to learn more

In view of the expected property price growth, Eli Lilly employees should consider their real estate as an important part of their wealth and determine their readiness to sell, recommends Tyson Mavar, a representative of The Retirement Group at Wealth Enhancement Group. 'Knowledge of the market trends and timings can make a huge difference to your financial returns.'

'Wesley Boudreaux of The Retirement Group at Wealth Enhancement Group recommends that Eli Lilly employees determine how the anticipated rise in home values will affect their personal financial plans. It is possible that delaying the decisions on the housing market, especially in the current economic environment, may improve their long-term financial position.'

In this article, we will discuss:

1. 'Forecasted Trends in Housing Prices: An analysis of the predicted rise in house prices by Bank of America and the possible positive implications for homeowners, particularly those from the Eli Lilly company in light of the pandemic and current mortgage rates.'

2. 'Economic Factors Influencing the Housing Market: Examining how changes caused by the pandemic, including increased remote working and preference for suburban areas, along with fluctuating mortgage rates, are influencing the present and future of real estate.'

3. 'Strategic Considerations for Home Selling: Examining the advantages and disadvantages of not selling a home until the prices rise and how population changes influence the housing market trends.'

Learn why it is beneficial to hold off on selling your real estate property in today’s market and how these tips can help you maximize your return on investment.

According to Michael Gapen, the Chief US Economist at Bank of America, the prices are still going to rise quickly. According to the bank, house prices will grow by 5% in 2025 and 4.5% in 2024. For the Eli Lilly employees who plan on selling their homes, it may be worth considering the post-pandemic world and the present mortgage rates. It might be better to wait for a few more years.

The property market has been on the rise post-pandemic and the values of homes have increased by 6% on average every year. This has created a very good market for those who own the properties. Bank of America has pointed out that this trend is likely to persist.

In their most recent analysis of the housing market, Gapen and his team expect prices to keep rising by 4.5% this year and 5% in 2025. They predict that there will be no cooling down of the market until the year 2026, which means that current homeowners, including those from Eli Lilly, might stand to benefit from waiting since higher sale prices may be possible in the near future.

The Virtue of Patience

There are several good reasons why it could be advantageous for homeowners to prevent selling. Gapen points out that the economic effects of the pandemic are still ongoing and may not reach their fullest in late 2025. This has also increased long-term housing trends such as working from home and preferring suburban areas which still keep the prices high. Another important factor for homeowners is the changing mortgage rates. Many got rates as low as 3% during the pandemic. With rates now sitting at 7%, it may actually be more advantageous to remain in one’s home. The Federal Reserve may cut rates later this year, but Bank of America believes it may take years for the difference between current and historical mortgage rates to disappear, which makes a strong case for staying in one’s home.

Possibility of Price Increases After 2026

Homeowners can expect price increases for the next two years at the minimum. If the impacts of the pandemic decrease to the point of almost being unnoticeable by the end of 2025, the market may level off and even experience a slight rise of 0.5% in 2026. The macroeconomic conditions are expected to improve, the housing supply is expected to increase, and the monetary policy is expected to loosen, which should bring down the prices. However, there is a possibility of prices rising even after 2026.

Historically, real personal discretionary income has been highly correlated with housing prices. As Bank of America notes, the current momentum in home prices may lead to sustainably higher prices than the fundamental values. This inertia provides homeowners, including those at Eli Lilly, with more opportunities for appreciation. If the effects of the pandemic are worse than expected, and the housing market remains strong, prices can rise another 5% by 2026. Furthermore, the population dynamics in the subsequent years will continue to stimulate housing demand. Millennials have now become the largest home buying segment and are likely to influence the market in a big way.

Therefore, it is recommended that a homeowner only considers selling their property when they are certain that they can sell at a higher price due to market trends. A recent Harvard University study pointed out that the percentage of older individuals with mortgage debts has doubled over the last three decades, which is good news for many retirees to wait out potential increases in property value.

This information is not intended as a recommendation. The opinions are subject to change at any time and no forecasts can be guaranteed. Investment decisions should always be made based on an investor's specific circumstances. Investing has its risks, including the possibility of losing principal.

Featured Video

Articles you may find interesting:

Loading...

  • Sources:

  1. Santarelli, Marco. 'Housing Market: Sell Now or Wait? What Does Bank of America Say?' Norada Real Estate Investing July 8, 2024,  www.noradarealestate.com/blog/housing-market-sell-now-or-wait/ . Accessed February 4, 2025.

  2. Dahl, Roxanne. 'According to Bank of America Economist, Housing Market is 'Stuck' Until at Least 2026.' Weekly Real Estate News, July 7, 2024, wrenews.com/bank-of-america-economist-housing-market-stuck-2026. Accessed February 4, 2025.

  3. Amelia. 'Bank of America: Housing Market Challenges Expected to Persist Until 2026.' Realty Biz Blog, 2024, realtybizblog.com/us-housing-market-stuck-until-2026. Accessed February 4, 2025.

  4. 'BoA Michael Gapen - Macro Economic Trends and Risks.' Motley Fool Community, September 11, 2022, discussion.fool.com/boa-michael-gapen-74773. Accessed February 4, 2025.

  5. 'Household Spending Remains Strong.' Bloomberg, undated, bloomberg.com/article/household-spending-gapen/. Accessed February 4, 2025.

What is the 401(k) plan offered by Eli Lilly?

The 401(k) plan at Eli Lilly is a retirement savings plan that allows employees to save a portion of their salary on a tax-deferred basis.

How does Eli Lilly match employee contributions to the 401(k) plan?

Eli Lilly offers a matching contribution up to a certain percentage of the employee's salary, which helps to boost retirement savings.

Can employees at Eli Lilly choose how their 401(k) contributions are invested?

Yes, employees at Eli Lilly can select from a variety of investment options for their 401(k) contributions, including stocks, bonds, and mutual funds.

What is the eligibility requirement for Eli Lilly's 401(k) plan?

Employees at Eli Lilly are typically eligible to participate in the 401(k) plan after completing a specific period of employment, usually within the first year.

How can Eli Lilly employees enroll in the 401(k) plan?

Eli Lilly employees can enroll in the 401(k) plan through the company’s online benefits portal or by contacting the HR department for assistance.

What are the contribution limits for Eli Lilly's 401(k) plan?

The contribution limits for Eli Lilly's 401(k) plan are set according to IRS guidelines, which can change annually. Employees should refer to the latest IRS limits for specifics.

Does Eli Lilly offer a Roth 401(k) option?

Yes, Eli Lilly provides a Roth 401(k) option that allows employees to make after-tax contributions, which can grow tax-free.

What happens to my Eli Lilly 401(k) if I leave the company?

If you leave Eli Lilly, you have several options for your 401(k), including rolling it over to another retirement account, cashing it out, or leaving it in the Eli Lilly plan if allowed.

Are there any fees associated with Eli Lilly's 401(k) plan?

Yes, there may be administrative fees or investment-related fees associated with Eli Lilly's 401(k) plan, which are disclosed in the plan documents.

How often can I change my contribution amount to the Eli Lilly 401(k) plan?

Employees at Eli Lilly can typically change their contribution amounts at any time, subject to the plan's rules and guidelines.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Eli Lilly offers comprehensive employee retirement benefits, including both pension plans and 401(k) plans. The Lilly Pension Plan is a Defined Benefit (DB) plan, where the pension is determined by an employee's earnings and years of service at the company. This pension plan has been updated over the years, with specific attention to tax and regulatory changes. Employees qualify based on their length of service and meet eligibility requirements outlined in Eli Lilly’s internal documents. The Lilly Pension Plan uses a final average pay formula to calculate the pension, meaning the pension is based on an employee's earnings during their final years of employment​ (SEC.gov). Eli Lilly also provides a 401(k) plan known as The Lilly Employee 401(k) Plan. This plan was established to help employees save for retirement, incorporating both employer contributions and employee savings. As of January 1, 2006, it was amended to include an Employee Stock Ownership Plan (ESOP) within the 401(k). Eligibility for the 401(k) plan includes all regular, full-time employees of Eli Lilly, as well as its subsidiaries and affiliates​ (SEC.gov). The company matches contributions and offers vesting schedules based on years of service. For instance, employees become fully vested after completing five years of service, as outlined in their official documentation​ (SEC.gov). The pension and 401(k) plan information for Eli Lilly has been extensively documented in their official filings with the SEC, where the detailed structure of the plans is outlined, including the qualifications for participation and vesting. Specific sections such as those covering mergers and eligibility requirements for different types of employees, including those under subsidiary plans, are found in their formal pension and 401(k) documentation​ (SEC.gov)​ (SEC.gov).
Restructuring and Layoffs: In 2023, Eli Lilly announced significant restructuring efforts, including the reduction of 3,500 jobs globally. This move is part of their strategy to save $500 million annually, with half of the savings aimed at product launches and R&D efforts. The layoffs are primarily focused on early retirement programs, site closures in New Jersey and Shanghai, and the consolidation of manufacturing locations​ (FiercePharma). This news is critical to address due to the current economic climate, where inflationary pressures and cost-cutting measures are widespread. The political environment also affects the pharmaceutical industry, making it crucial to track how companies like Eli Lilly adjust their workforce to stay competitive​ (FiercePharma).
Eli Lilly provides its employees with both stock options and Restricted Stock Units (RSUs) as part of its long-term incentive compensation. These RSUs are issued to employees and are subject to a vesting schedule, typically staggered over a period of time such as one, two, or three years. The goal is to retain employees by ensuring they receive full ownership of the stock only after they have fulfilled a specified period of service with the company​ (BusinessOwnerAdvisor). Stock options at Eli Lilly grant employees the opportunity to purchase company stock at a predetermined price, typically at the market value on the grant date. These options often vest over several years, with employees being able to exercise them once they are vested. RSUs, on the other hand, provide employees with company shares once they are fully vested, and these shares are taxed as ordinary income at the time of vesting. Employees are responsible for deciding whether to sell the shares immediately or hold onto them, which involves considering factors like tax implications and portfolio diversification​ (Eli Lilly and Company)​ (Eli Lilly and Company). RSUs and stock options at Eli Lilly are available to a broad group of employees, typically those in management and other key roles. The availability of these stock-based compensation forms reflects Eli Lilly's commitment to aligning employee incentives with company performance, and they play a crucial role in employee retention​ (BusinessOwnerAdvisor).
Eli Lilly has been making significant strides in its healthcare offerings, particularly through the launch of its digital platform, LillyDirect. This platform focuses on providing support for patients with chronic illnesses such as obesity, diabetes, and migraines. By enabling patients to access telehealth services and facilitating direct home delivery of certain medications, Eli Lilly has made healthcare more accessible and streamlined for patients dealing with these conditions. Additionally, LillyDirect offers educational resources and digital pharmacy solutions, making it easier for patients to refill prescriptions and receive medications at home. This initiative is crucial as it caters to a growing need for convenient healthcare, especially in light of the current economic pressures and the healthcare industry's shift towards digital solutions​ (PYMNTS.com)​ (PYMNTS.com). In the broader context of Eli Lilly's healthcare initiatives, the company's focus on digital healthcare aligns with current trends in healthcare delivery. The importance of platforms like LillyDirect is underscored by the economic and political pressures on the healthcare system, particularly as patients seek cost-effective and accessible treatments. Moreover, the growing political discourse around healthcare reform, coupled with tax implications for pharmaceutical benefits, further highlights the relevance of Lilly's approach. By offering services such as telehealth and home delivery, Eli Lilly is positioning itself at the forefront of healthcare innovation, which is critical for ensuring patient satisfaction in a competitive market​ (PYMNTS.com)​ (HealthCare ME&A Magazine).
New call-to-action

Additional Articles

Check Out Articles for Eli Lilly employees

Loading...

For more information you can reach the plan administrator for Eli Lilly at Lilly Corporate Center Indianapolis, IN 46285; or by calling them at (317) 276-2000.

https://www.marketbeat.com/stocks/NASDAQ/LKQ/#google_vignette https://csimarket.com/stocks/competitionSEG2.php?code=LLY#google_vignette https://investor.lilly.com/news-releases/news-release-details/lilly-reports-first-quarter-2024-financial-results-and-raises https://www.fiercepharma.com/pharma/lilly-to-cut-3-500-jobs-take-a-1-2b-hit-as-it-aims-for-500m-savings https://www.fiercepharma.com/pharma/lilly-to-cut-3-500-jobs-take-a-1-2b-hit-as-it-aims-for-500m-savings https://www.preqin.com/data/profile/investor/eli-lilly-&-company-pension-plan/2785 https://www.thewealthadvisor.com/article/how-eli-lillys-pension-gets-weird-results https://elilillygrouppensionplan.co.uk/about-the-plan/introducing-the-plan https://elilillygrouppensionplan.co.uk/news/update-on-the-lifetime-allowance https://www.milliman.com/en/ https://www.sec.gov/Archives/edgar/data/59478/000119312511045355/dex41.htm https://www.thomaskopelman.com/blog/the-key-details-of-rsus-using-eli-lilly-as-an-example https://investor.lilly.com/financial-information/annual-reports https://investor.lilly.com/sec-filings/sec-filing/11-k/0000059478-23-000203 https://turbotax.intuit.com/tax-tips/retirement/net-unrealized-appreciation-nua-tax-treatment-amp-strategies/c71vBJZ2B https://www.thomaskopelman.com/blog/the-key-details-of-rsus-using-eli-lilly-as-an-example https://www.pymnts.com/healthcare/2024/can-eli-lilly-with-lillydirect-change-the-delivery-of-healthcare/ https://www.pymnts.com/healthcare/2024/eli-lilly-debuts-digital-healthcare-platform-for-chronic-illness-patients/ https://www.pymnts.com/healthcare/2024/eli-lilly-debuts-digital-healthcare-platform-for-chronic-illness-patients/ https://www.healthcaremea.com/tag/eli-lily/ https://careers.lilly.com/us/en/pay-and-benefits https://elilillygrouppensionplan.co.uk/about-the-plan/retiring-from-lilly https://investor.lilly.com/financial-information/annual-reports https://elilillygrouppensionplan.co.uk/about-the-plan/benefits-in-retirement https://www.kiplinger.com/taxes/tax-planning/604591/net-unrealized-appreciation-a-hidden-tax-strategy https://www.kitces.com/blog/net-unrealized-appreciation-irs-rules-nua-from-401k-and-esop-plans/ https://www.schwab.com/resource/NUA https://www.investopedia.com/terms/n/netunrealizedappreciation.asp https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-point-biopharma-expand-oncology-capabilities-next https://www.insidearbitrage.com/2024/07/eli-lilly-finalizes-acquisition-agreement-with-morphic-for-3-2-billion/ https://www.thelayoff.com/eli-lilly-and?page=2#google_vignette https://contracts.justia.com/companies/lilly-eli-co-803/contract/1054940/ https://www.investopedia.com/articles/personal-finance/102215/benefits-deferred-compensation-plans.asp https://www.nerdwallet.com/article/investing/deferred-compensation https://www.nasdaq.com/articles/lly-earnings-eli-lilly-reports-impressive-q2-results-huge-revenue-increase

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Eli Lilly employees